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Adeno-associated virus (AAV) has been reported to integrate in a site-speciﬁc manner into chromosome
19 (a site designated AAVS1), a phenomenon that could be exploited for ex vivo targeted gene therapy.
Recent studies employing LM-PCR to determine AAV integration loci; however, have, contrary to
previous results with less reliable methods, concluded that the proclivity for AAV integration at AAVS1
is minimal. We tested this conclusion employing LM-PCR protocols designed to avoid bias. Hep G2 cells
were infected with rAAV2-GFP and coinfected with wt AAV2 to supply Rep in trans. Sorted cells were
cloned and cultured. In 26 clones that retained ﬂuorescence, DNA was extracted and AAV-genomic
junctions ampliﬁed by two LM-PCR methods. Sequencing was performed without bacterial cloning. Of
these 26 clones it was possible to assign a genomic integration site to 14, of which 9 were in the AAVS1
region. In three additional clones, rAAV integration junction were to an integrated wt AAV genome
while two were to an rAAV genome. We also show that integration of the AAV-GFP genome can be
achieved without cointegration of the AAV genome. Based on the pattern of integrants we propose, for
potential use in ex vivo targeted gene therapy, a simpliﬁed PCR method to identify clones that have
rAAV genomes integrated into AAVS1.
& 2012 Elsevier Inc. All rights reserved.Introduction
Recently, in order to minimize the potential long-term risk of
insertional mutagenesis, efforts to accomplish gene transfer in
mammalian cells have begun to explore targeted gene transfer to
cells ex vivo. A cell identiﬁed as having a correctly targeted gene
can then be expanded for subsequent implantation.
The use of nucleases e.g. ZFN or Tal, to accomplish this
targeting has been a promising development but nuclease toxicity
in the targeted cell merits caution. This ZFN toxicity, as measured
by cell death, is apparently due to off target cleavage (Cornu and
Cathomen, 2010). Two recent studies have shown that there is at
present no reliable method to either predict or determine off
target cleavage by designed nucleases (Gabriel et al., 2011;
Pattanayak et al., 2011).
An alternative, that minimizes the risk of insertional mutagen-
esis, is the use of adeno-associated virus (AAV) based vectors. AAV
based vectors are thought to remain episomal but nevertheless to
provide long-term expression in non-dividing cells. However,
while episomal vectors are acceptable in many situations they
are unsuitable for transduction of cells that will be expanded.
Moreover, even in apparently stationary cells episomal rAAVll rights reserved.
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h.org (C.E. Walsh).vectors are gradually lost, a phenomenon that may be due to
low levels of cell division (Wang et al., 2011). In addition, recent
studies in cell culture and in mouse models have shown that a
small but signiﬁcant percentage of recombinant AAV vectors do
integrate. This integration is apparently random, at positions
similar to those seen with retroviral insertions (Miao et al.,
1998; Miller et al., 2002; 2005; Nakai et al., 1999; 2003; 2005;
Ponnazhagan et al., 1997; Rutledge and Russell, 1997; McCarty
et al., 2004). Concerns with designed nucleases, the limitations of
rAAV episomes in dividing cells, and the possibilities of inser-
tional mutagenesis lead to consideration of using the ability of
AAV to perform site-speciﬁc integration for targeting AAV-based
vectors (Henckaerts and Linden, 2010).
Wild type AAV is unique among known eukaryotic DNA
viruses in that, in cultured cells, it can integrate its genome into
the host cell’s genome at a speciﬁc site, a region in chromosome
19 at 19q13.4 that has been designated AAVS1 (Kotin et al., 1990;
Samulski et al., 1991). This region of chromosome 19 is the locus
of the gene MBS85 (myosin binding subunit 85) also known as
PPP1R12C (protein phosphatase 1, regulatory inhibitor subunit
12C) (Dutheil et al., 2000; 2004; Tan et al., 2001).
Recombinant AAV vectors are produced with the viruses’ two
open reading frames, designated Rep and Cap, omitted to allow
for maximum transgene capacity. The AAV Rep protein is required
for targeting of AAV to the AAVS1 region (McCarty et al., 2004;
Surosky et al., 1997), Recombinant AAV vectors, which necessarily
do not carry the Rep gene, when they do integrate, have not been
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To accomplish integration into AAVS1 with rAAV vectors Rep
must therefore be supplied in trans. Additional requirements for
AAV integration at AAVS1 are the presence and correct spacing of
motifs occurring naturally at the AAVS1 locus and which resem-
ble the viral Rep binding site (RBS) and terminal resolution site
(TRS) found in the viral ITR(Linden et al., 1996a; Meneses et al.,
2000). In the AAV genome these motifs function as the viral
origins of DNA replication (Muzyczka and Berns, 2001). The
integrating vector should also possess an RBS. The precise
mechanism of targeted integration is not known but is thought
to involve a multimer of the Rep protein simultaneously binding
to the RBS in both the viral vector and in the AAVS1 region
(Weitzman et al., 1996). It is likely that the Rep protein induces
unidirectional strand displacement DNA replication from the TRS
in AAVS1 in the same manner as it induces replication of the viral
genome (Urcelay et al., 1995) and that at some point downstream
the replication complex switches from using chromosomal DNA
as template to using the viral genome thereby copying the viral
genome into chromosome 19 (Kotin, 1994; Linden et al., 1996b).
Efforts to develop ex vivo targeted gene delivery have, with
rare exceptions, not attempted to appropriate the capacity of Rep
to deliver a rAAV vector to AAVS1. This is despite several recent
reports showing that transgenes delivered to the AAVS1 region
demonstrate robust long term expression without detectable
harm to the cell (Henckaerts et al., 2009; Ramachandra
et al.,2011; Smith et al., 2008; Zou et al., 2011). Two principle
reasons for this neglect are ﬁrst, the belief that the necessity of
supplying Rep in trans for rAAV vectors makes it impossible to
target these vectors at a usable level of efﬁciency and second,
recent reports showing that Rep does not target even wt AAV
preferentially into the AAVS1 region.
The standard method to determine if an AAV based vectors is
inserted at AAVS1 has been Southern hybridization. In addition to
producing results often difﬁcult to interpret, in part because Rep
will induce rearrangements at AAVS1 in the absence of integration,
Southern hybridization only determines the presence or absence of
integration at AAVS1. It remained possible that there are many
other Rep-directed integration targets dispersed throughout the
human genome. This possibility was tested in two recent investiga-
tions (Drew et al., 2007; Huser et al., 2010). Those studies isolated
wt AAV integrants by using variants of LM-PCR, since LM-PCR is not
biased towards AAVS1 and could therefore be expected to uncover
integration hot-spots missed previously. In one report AAVS1
targeting was a minor fraction of the recovered proviral genomes,
in the other it was not detected. (In the latter report, AAVS1
integration could be readily detected by PCR employing primers
from AAVS1, consistent with the notion that AAVS1 integration did
occur but was a minor component of total integration.)
In our experience LM-PCR as employed in the above two
reports would bias the results towards integrants with less
complete viral ITRs. Since virally supported, i.e. Rep-directed,
integration might produce integrants with more complete ITRs
(required for efﬁcient rescue of the provirus; Ward et al., 2003)
than integration supported only by cellular factors we have
revisited this question. Our working hypothesis therefore is that
AAVS1 integrants are harder to detect by LM-PCR than non AAVS1
integrants. Using LM-PCR approaches, that reduce an anti-ITR
bias, we ﬁnd that in the presence of Rep, the majority of rAAV
integrants are found at AAVS1.Results
A principle aim was to determine if, when the locus of Rep-
directed rAAV integrants is obtained by LM-PCR, modiﬁed to reducebiases in that methodology, integrants would be found preferen-
tially in the AAVS1 region. A second aim was to develop an
improved method for determining whether a clone has an rAAV
genome integrated into AAVS1 for the purposes of selecting clones
for ex vivo gene therapy. Importantly, among the techniques to
determine the genomic location of rAAV genomes, only LM-PCR at
present produces a result of the certitude needed for reimplantation.
Due to the small size of the AAV viral particle the Rep gene,
necessary for site-speciﬁc integration, has typically been supplied
in trans. This is commonly done by cotransfection of two plasmids
into the target cell, one containing the AAV ITRs ﬂanking a
transgene and the second plasmid with the AAV Rep gene.
Disadvantages of this method are the effects on the cell of the
transfection protocol, likelihood that plasmid domains external to
the ITRs will also be inserted into the cells’ genome (Surosky et al.,
1997), and lower efﬁciency. For these reasons, as well as the
ability of AAV to infect many cell types, and most importantly for
the apparent harmlessness of wt AAV, we chose to use co-
infection with two viruses. The ﬁrst was a standard recombinant
AAV and the second, to supply Rep, a wild type AAV (Henckaerts
et al., 2009; Zhang et al., 2007).
Titration of wild type AAV
Since production of Rep protein requires that the AAV genome be
ds and since there is evidence that Rep targeted integration is
preferentially of ss genomes (Daya et al., 2009) it is likely that even
wt AAV integration is often a trans phenomenon. To assess whether
co-infection with a wild type virus enhanced integration of the
recombinant virus, a 35mm plate of the transformed liver cell line
Hep G2 was infected with an AAV2 serotype vector encapsidating a
GFP genome, AAV2–TRUF11, (Zolotukhin et al., 1996) while a
comparison well was infected with AAV2–TRUF11 plus wt AAV2.
(Hep G2 cells were used in a previous study that concluded the
AAVS1 region was not a common site for wt AAV integration; Drew
et al., 2007). The cells were passaged several times and positive cells
were determined by EGFP ﬂuorescence. Cells remaining positive after
multiple passages are likely to have an integrated AAV2–TRUF11
genome. We used 1.25108 gcp of recombinant virus for each
35mm well. We reasoned that if the addition of Rep in trans in the
form of wt AAV can result in Rep-targeted integration we would
expect to see an increase in stably transduced cells. (It has been
demonstrated that the integration rate of recombinant AAV vectors is
low, i.e. at most a few percent of the infected cell population; Nakai
et al., 2003; Rutledge and Russell, 1997).
To reduce the likelihood that most site speciﬁc integration
would be of the wt AAV genome or that cells found to have a rAAV
genome at AAVS1 might also have a copy of the Rep gene
integrated elsewhere we infected with approximately 1/10 as
much wt virus as recombinant virus, i.e. 1.5107 gcp per well of
wt AAV. After several passages the percentage of cells that
remained transduced showed only a slight increase with the
addition of wt AAV (data not shown).
To test whether greater amounts of wild type virus would
increase the number of cells stably expressing the GFP gene we
co-infected plates of Hep G2 cells with identical amounts of
AAV2–TRUF11 (the same as above) but with several levels of wt
AAV. The ratios tested were approximately 0.1/1, 0.3/1, 1/1 and
3/1 of wt to recombinant virus. Cells were passaged multiple
times with transduction assessed by a FACS analysis at each
passage. It is likely that stable transductants are Hep G2 cells that
have a functional integrated copy of the AAV–TRUF11 genome.
Fig. 1 shows the percent of green cells after this percentage had
reached a relatively constant level in each plate. Adding wt AAV2
did increase the number of cells with stable expression; with the
highest level tested more than doubling the percentage of stably
Fig. 1. Titration of wt AAV2. Four plates of Hep G2 cells were infected with
1.25108 vector genomes of AAV2–TRUF11 virus. Plates were coinfected with
0.15, 0.4, 1.3, and 3.8108 of wt AAV. This is an approximate ratio of wtAAV/rAAV
of 0.1/1, 0.3/1, 1/1, 3/1. After 3 passages, cells were harvested and the percentage
of GFP expressing cells was determined by FACS analysis.
Table 1
Percent of stably transduced cells after infection with AAV2–TRUF11 comparing
infection with and without coinfection with wt AAV2. Amount of AAV2–TRUF11
virus was the same for both plus and minus wt AAV2 coinfections. A,B,C, were
infections of non conﬂuent cells. D was infections of conﬂuent cells.
wt AAV2  þ
A 0.3 1.2
B 0.50 0.91
C 2.4 4.2
D 0.067 0.091
Table 2
FACS analysis of various populations at each passage.
Inf. 1st 2nd 3rd 4th
Uninf 0.01 0.0 0.04 0.02
TRUF11 18.5 0.8 0.43 0.30
TRUF11þwt 27.4 2.4 1.72 1.23
Shown is the % of cells positive for FITC signal at each passage , i.e.
cells that were present in region P11 of Fig. 3.
Fig. 2. Photomicrograph of a cluster of GFP expressing cells, prior to sorting, in
a plate coinfected with wt AAV and AAV–TRUF11. Top panel shows conﬂuent
cells after several passages post infection under UV light. Bottom panel is same
ﬁeld under visible light.
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cells in 4 additional assays. Each of these four assays employed
the same amount of rAAV as the assay of Fig. 1 and 3X as much wt
AAV. The assay designated ‘‘D’’ used Hep G2 cells which had
reached conﬂuence shortly before infection. As expected, there
was a minimal amount of stable transduction in ‘‘D’’. The values
from assay to assay vary greatly but in each case there was an
increase in stable transductants upon the addition of wt AAV.
Collectively these ﬁve assays encourages the notion that coinfec-
tion with wt AAV might support the integration of measurable
amounts of rAAV vectors.
If viral uptake is limiting, more wt AAV might reduce the
number of rAAV particles available for integration. That we
nevertheless see increasing numbers of stably green cells with
increasing wt AAV but constant amounts of rAAV reinforces the
notion that wt AAV is supporting integration of the rAAV genome.
Integration into AAVS1
To determine whether the additional integration of rAAV
genomes that was supported by wt AAV coinfection was prefer-
entially into AAVS1 we chose to analyze infection ‘‘A’’ of Table 1.
To describe this assay more completely: 6-well plates of Hep G2
cells at 30% conﬂuence were infected with AAV2–TRUF11 with or
without coinfection with wt AAV2, ampliﬁed to conﬂuence,
transferred to 100 mm plates, and again ampliﬁed to conﬂuence.
We designated the passage from the 6-well plate to the 100 mm
plate as passage 1. At subsequent passages the cells were split
20:1. At each passage FACS analysis measured the percentage of
cells positive for GFP expression. The results are shown in Table 2.
As expected the percentage of positive cells fell dramatically
between the ﬁrst and second passages but less quickly thereafter.
In addition to monitoring the total number of positive cells by
FACS analysis, the distribution of the cells on the plates wasmonitored by visual inspection. Within a few passages almost all
the positive cells were no longer found as single cells but were in
several hundred individual clusters of many positive cells each.
Fig. 2 is a photomicrograph showing clusters of GFP expressing
cells. We reasoned that these clusters most likely represented
clones in which a copy of the TRUF11 genome had become
integrated into the cell’s genome. Single cells are likely those in
which an episomal TRUF11 genome has been retained or in which
a recombinant viral particle uncoated only after several passages.
When almost all positive cells were found as members of clusters
of green cells and not as isolated green cells, we sorted the cells for
FITC expression. It is likely that if we had passaged the cells
Fig. 3. FACS analysis of cells at sorting. Shown is a dot plot of 20,000 cells from uninfected Hep G2 cells, Hep G2 cells infected with only AAV2–TRUF11, Hep G2 cells
infected with both AAV2–TRUF11 and wt AAV2. Shown is FITC vs PE-A. The region designated ‘‘P11’’ is the region from which randomly selected cells were ampliﬁed.
Table 3
Distribution of clones from AAV2-TRUF11þ wt AAV infected cells.
LM-PCR Nla/InvLM-PCR
AAV non AAVS1 AAVS1
No PCR product 8 1 4
Unable to determine junction 6 1 1
Junction not in AAVS1, but genomic 4
Junction in wt AAV sequences. 2
Junction in TRUF11 sequences 2
Junction in AAVS1 region 4
Clones no longer green 3
DNA from 29 clones was processed by LM-PCR to assign ITR-chromosomal
junctions. Clones scored as positive for AAVS1 had sequences that demonstrated
a juxtaposed AAV2–TRUF11 primer, ITR sequences, AAVS1 sequences. There were
no Nla 3 sites in these sequences and at most 1–2 unaccounted for bases between
the viral ITR and AAVS1 sequences. Shown at right are the junctions determined
by Nla/Inv LM-PCR from the 8 ‘‘No PCR product’’ and 6 ‘‘Unable to determine’’
clones from the standard LM-PCR.
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likely to be expressing GFP from an episomal form. However we
were concerned that growth in culture might distort the population
of cells with integrated genomes by relative selective growth
advantages between different clones. Fig. 3 is a FACS proﬁle of
the cells at the time of sorting comparing uninfected; AAV2–
TRUF11 infected; and AAV2–TRUF11, AAV2 coinfected cells. Shown
is the boundary line by which cells were classiﬁed as either positive
or negative for sorting. We sorted cells by ratio of FITC signal to PE
signal rather than by FITC signal alone. This was so as to not discard
the lower expressing cells and thereby bias the results. It has been
suggested that rAAV genomes that are integrated into AAVS1 on
average express better than genomes integrated elsewhere.
As seen in Tables 1 and 2, approximately 1.2% of the cells that
had been infected with both viruses were classiﬁed as expressing
GFP compared with 0.3% of the cells receiving only the GFP
expressing virus. To determine what fraction of positive cells had
an AAV2–TRUF11 genome integrated into the AAVS1 region, we
randomly cloned 30 single cells from among those positive in the
sort, (i.e. without knowing their individual level of FITC ﬂuores-
cence). Clones were grown to 200,000 cells prior to harvesting. One
clone was lost during processing. Visual inspection at the time of
harvesting determined that 3 of the clones were not visibly green.
As mentioned it is not known how strong the FITC signal was
in the individual cells from which these clones were generated.
A possibility for absence of FITC signal in a clone is that at sorting
the progenitor cell was close to the boundary line separating
positive and not positive and did not possess a functioning
TRUF11 genome. Alternative possibilities are that at the time of
sorting these clones possessed only an episomal genome that was
subsequently lost, or that they had an integrated TRUF11 genome
that was subsequently silenced.
To determine the chromosomal locations of the integrated
AAV2–TRUF11 genomes, we extracted DNA from each clone and
performed LM-PCR followed by direct sequencing of the PCR
products, i.e. without bacterial cloning. Genomic locations were
determined by a search as described in M&M. Table 3 shows the
distribution of the clones, 26 of which had remained positive for
FITC expression. With a standard nested LM-PCR protocol we were
able to determine the genomic location of only 8 of these clones.
4 had identiﬁable genomic locations, other than AAVS1 while
4 clones demonstrated a junction in the AAVS1 region. These
4 junctions were between the left ITR of AAV2–TRUF11 and
sequences at approximately 0; 800; 18,000; and 51,000 bases
downstream of the TRS site in AAVS1(Fig. 4A). Experience sequen-
cing ITR junctions of plasmid DNA has demonstrated a need forcaution when trying to determine exact ITR junctions. In all these
cases the Sequencing Core produced sequences with deletions in
both the ITR and the adjacent plasmid vector backbone at this
junction. This is presumably the result of polymerase skipping due
to ITR secondary structure. As seen in Fig. 4(B), illustrating the
junctions on the AAV2–TRUF11 ITR, all of the integrants we
successfully mapped were missing an extensive portion of the
ITR suggestive of either polymerase skipping or of an inability of
our PCR methodology to produce a product when junctions
contained a more complete ITR. For 4 additional clones we
identiﬁed junctions with AAV or AAV–TRUF11 sequences rather
than genomic sequences. In all cases these integrants were not of
ITR to ITR but rather of AAV2–TRUF11 ITR to internal AAV2–
TRUF11 or wt AAV2 sequences, suggestive of a genuine integra-
tion. In the case of integration into AAV2, one insertion was into
the Cap gene and the other into the Rep gene. Of the 13 clones in
which we were not able to determine the adjacent sequences,
8 failed to give a distinct band on the second, nested PCR. The
6 remaining clones gave unreadable sequences, in most cases
because more than one species of DNA was being sequenced.
Wild-type AAV integrants
Since we coinfected with wild type AAV2 to supply Rep in trans,
the wild type virus would also be expected to integrate its genome
into some portion of the infected cells. Since it is likely that wt
AAV2 should integrate as or more efﬁciently than the recombinant
Fig. 4. (A) Schematic of the 4 integrants into chr 19q13.4. Integrants are
designated 1–4. Boxes represent the three genes in this region with transcription
proceeding from dark to lighter. Below are the names of the genes (Myosin
binding subunit 85, Epidermal growth factor receptor kinase substrate 8-like
protein1, Retinol dehydrogenase 13), their respective length in kilobases, and the
length of the intergenic regions. The integration sites designated 2,3,4 would seem
by NCBI Reference Sequence Map AC_000062.1 to be located within introns. Also
shown are the location of the AAVS1 TRS and RBS. (B) Schematic showing relative
location of junctions in AAV2–TRUF11 ITR.
Fig. 5. PCR analysis to determine the presence of the integrated wild type AAV genom
DNA (equivalent to approximately 2000 cells) isolated from clones 15, 14, 12, and 5
reactions done in parallel with an amount of linearized AAV plasmid DNA (pAV2) equi
ﬁfth clone. The arrow indicates the Rep PCR product. Clone 14 demonstrates integrated
copy per cell.
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much wt virus as recombinant virus, the expectation is that a
substantially higher proportion of the cells should have wt AAV2
integrations. It is also possible that integration of the wild type
genome and of the recombinant viral genome are linked. For example,
it might be that cell with a stably integrated wt AAV genome produce
Rep in quantities more likely to result in integration of the rAAV
genome. In that case the likelihood of having integrated copies of
both in the same cell would be higher than expected by random
chance. To determine whether the clones with an rAAV integrated
into the AAVS1 region also contained an integrated Rep gene, we
performed a PCR on DNA from these four AAVS1 positive clones with
Rep speciﬁc primers. As standards we added known amounts of the
AAV genome derived from the plasmid pAV2. The results are seen in
Fig. 5. One clone, clone 14, gave a strong signal indicating at least one
integrated copy of the wild type AAV genome or fragment from the
Rep gene. (Sequencing of this fragment with internal primers
conﬁrmed that it was the AAV Rep gene.) We determined the
chromosomal location of this integrated wt AAV genome using Nla/
Inv LM-PCR as described below; it was located in the AAVS1 region.
Of additional interest is the band in clone 5. This band is fainter
than the standard of one genome equivalent per cell suggesting that
it is present at less than one copy per cell. (There is the possibility of
a very faint band at this position in the other lanes.) It is likely that
the band of clone 5 represents an integration event that occurred in
one cell several cell divisions after single cell sorting so that a
substantial fraction, but not all, of the cells of this clone contained an
integrated AAV2 genome. An implication is that integration of the
wild type genome was not necessary for integration of the TRUF11
genome in clone 5 as it was not in clones 12 and 15.Second method for determining junctions
Fig. 4 demonstrates extensive deletions in the ITRs of the clones
whose locations in AAVS1 we were able to determine. This ise in clones with AAV–TRUF11 integrated in the AAVS1 region. One percent of the
was subjected to PCR with Rep speciﬁc primers. The right three lanes show PCR
valent to 0, 0.1, or 1.0 copies per genome added to one percent of the DNA from a
Rep DNA at least one copy per cell. Clone 5 demonstrates Rep DNA at less than one
Fig. 6. Schematic illustrating Nla/Inv PCR. Genomic DNA is digested with Pst 1,
ligated to itself, digested with Nla 3, then ligated to adapters. Nested PCR is
performed with adapters shown. Heavy arrows designate primers in AAV2–
TRUF11. Lighter arrows designate adapter primers. Open box is junction between
AAV2–TRUF11 ITR and genomic sequences. Heavy vertical line is ligation point
between AAV2–TRUF11 Pst 1 site and closest genomic Pst 1 site to left of vector/
genomic junction. P – Pst 1. N – Nla 3.
Fig. 7. Schematic of circular ligation of a clone showing location of ligation of
AAV2–TRUF11 Pst 1 site with AAV Pst 1 site at AAV base 495. Going clockwise
from this ligation point towards the junction The AAV sequences rise. Therefore
the junction of AAV2–TRUF11 with AAV2 must be between the AAV2 Pst 1 sites at
495 and 1958. Junction between AAV2 and AAV2–TRUF11 genomes is denoted by
black box.
Fig. 8. (A) Schematic illustrating location of Pst 1 sites in AAVS1 proximal to
vector/genomic junctions as determined by Nla/Inv PCR. Nucleotides are
numbered from AAVS1 TRS site. Pst 1 site at AAVS1 base 1027 is ﬁrst Pst 1 site
to right of TRS. Pst 1 sites at 11681 and 13629 are adjacent. Adjacent to each Pst
1 site is a horizontal double line illustrating the direction of genomic sequences in
the PCR product.(B) Schematic (adapted from Henckaerts et al., 2009) of
integration pattern of known wt AAV2 integrants into AAVS1. Integrated viral
genome is designated by heavy line. Heavy numbers are approximate nucleotides
of AAVS1 site at respective junctions. TRS site is set at 1. Sequences to right of
integrant are a duplication of genomic sequences near and to the right of TRS site.
These nucleotides continue rightward. Light numbers show position of Pst 1 site at
1027 in AAVS1. P – Pst 1.
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useful to attempt to locate the integration locus of the remaining
clones by a PCR method that does not involve the PCR polymerase
passing through the ITR. We elected to use an inverse PCR method
(which we call Nla/Inv PCR) as diagrammed in Fig. 6. The same
genomic DNA as employed above was digested with an enzyme with
a six base recognition sequence (in this case Pst 1). Molecules were
then ligated and digested again with Nla 3. Subsequently the same
adapter as used above were ligated to these fragments and PCR
reactions were performed as described. By performing the ﬁrst
ligation at a low DNA concentration we could bias the ligations
towards circularization as opposed to random end to end joining.
However the greater the distance between the ITR and the closest Pst
1 site in the genomic region the less the bias towards circular ligation.
The retrieved DNA sequence is of course not immediately at the
junction but rather at the closest Pst 1 site. This is sufﬁcient to
determine whether integration is into the AAVS1 region. Random end
to end joining of Pst 1 fragments does occur but each of the random
joinings will be to a different sequence and the question is whether
the circular ligation is working well enough for sequencing to identify
it above the background signal from a population of random ligations.
Since there are an estimated 500,000 Pst 1 sites in the human genome
the chances of randomend to end joinings beingwith a Pst 1 fragment
from the AAVS1 region are low. With this method we were able, as
shown in Table 3 to identify integration regions of 7 additional clones.
One was a random integration, one was into the AAV genome, and
ﬁve were into the AAVS1 region.
Fig. 7 is a schematic of a clone integrated into the AAV genome.
The two AAV integrants identiﬁed as being into AAV by means of
standard LM-PCR showed integration into the Cap gene in one case
and into the Rep gene in the other case. However a caution is that if
these integrants had been formed by recombination at the ITRs
between wt AAV and AAV2–TRUFF11 genomes before integration
then the integrant would contain a perfect ITR with two copies of the
D-region. It is possible that such an ITR might cause the polymerase
to dissociate and resume synthesis further downstream, i.e. at aninternal AAV sequence. However, the clone diagrammed in Fig. 7
since the PCR does not involve an ITR, does not present this
possibility. Since the sequence identiﬁed is reading upwards from
the Pst 1 Site in AAV, the actual junction in the AAV genome must be
further from the AAV ITR, i.e. between the AAV Pst 1 sites at 495 and
1958. This demonstrates that the rAAV–wtAAV junction is not due to
recombination between the ITRs but by integration of the rAAV into
an internal region of the wt AAV genome.
Fig. 8(A) is a schematic showing the Pst 1 sites of the 5 AAVS1
integrants recovered by the Nla/Inv PCR, designated by clone number.
Four were integrants determined from the left side of AAV2–TRUF11,
one clone, clone 4, was from the right side. While the exact junction is
not determined, Nla/Inv PCR, since it is not subject to the skipping
induced by the AAV ITR is, within its limits, more certain to give a
deﬁnite junction region. For instance clones 22 and 29 most likely
integrated between the TRS site and the Pst 1 site at 1027, which is
the closest Pst 1 site centromeric to the TRS in the chromosome 19
AAVS1 region. Also shown is the direction of the sequences at these
ﬁve sites. What is of note is that all ﬁve sites ﬁt the pattern seen for
the integration loci of the 6 wt AAV integrants for which both
junctions have been determined. (summarized in Henckaerts et al.,
2009). The pattern of integration of those 6 wt genomes, in which the
Rep gene end of the AAV genome is always found closest to the
AAVS1 TRS, supports the notion that sequences within the wt AAV
genome (most likely the p5 promoter region Philpott et al., 2002b)
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internal AAV sequences our ﬁve integrants have this same pattern.
Not only do the integration sites correspond but in each of the ﬁve
cases the genomic sequences are on the side of the genomic Pst 1 site
that would be predicted by the model of integration. (Henckaerts
et al., 2009). Fig. 8(B) is a diagram of this model showing the
predicted adjacent sequences if integration is according to this model.
The results from these 5 clones suggest that despite the absence of a
p5 promoter region the mechanism of rAAV integration is quite
similar to wt AAV integration. The only apparent difference being that
in the case of rAAV genomes there is, in contrast to integration of wt
AAV genomes, no preference for which end of the integrant is
centromeric or telomeric.Fig. 9. (A) Schematic illustrating AAVS1/Inv PCR. Shown are the AAV2–TRUF11
genome with Pst 1 sites indicated and primer pairs. Each arrow represents
2 primers for doing nested PCR. Also shown is the AAVS1 region prior to
integration with the AAVS1 primer pair designated by an arrow. After integration
into AAVS1 one end or the other of virus will be inserted into AAVS1 region
between TRS and Pst 1 site at 1027. After circularization PCR is with primer set
from one end or the other of vector and with primer set from AAVS1. Rectangle is
vector ITR. Heavy line represents rAAV sequence; light line represents genomic
sequence. Heavy arrows are primer sets from AAVS1. P – Pst 1.(B) Ethidium
bromide stained agarose gel showing the products of AAVS1/Inv PCR of clones
22 and 29. The right two lanes are the products of the ﬁrst round PCR, the left two
lanes are the products of the second round (nested) PCR. Arrow designates product
of correct sequence.Method for determining whether clones have a rAAV genome
integrated at AAVS1
Routine screening of clones to identify those with AAVS1
integrants would require a method that is simple and reliable.
The standard LM-PCR fails to identify many such clones. The Nla/
Inv LM-PCR method is technically challenging. The pattern of
5 Nla/Inv PCR integrants, as shown above, suggests a simpler
method that we call AAVS1/Inv PCR, Fig. 9. In this method a set of
nested primer sequences in the AAVS1 region that are at some
distance from and directed away from the TRS are chosen. They
need only be between the TRS and the ﬁrst site recognized by the
chosen restriction enzyme. If different enzymes are chosen for
AAVS1 digestion and vector digestion, circular ligation can be
accomplished with a linker. These primers are used to perform
inverse PCR as in the Nla/Inv PCR described above rather than
primers particular to a ligated adapter. The vector primers are the
same as used in Nla/Inv PCR. The disadvantage of this method is
that it is biased by use of a primer set speciﬁc to the AAVS1
region. As such it is not sufﬁcient for deriving a complete and
accurate picture of AAV or rAAV integration only for determining
if there is a rAAV integrant at AAVS1. However it has several
advantages as a method for screening clones to determine which
contain site-speciﬁc integrants or examining populations to
determine a frequency of integration into AAVS1. Like the inverse
PCR above it avoids the problem of synthesis through the ITR. In
addition it is procedurally simpler, requiring only one digestion
and one ligation before PCR. Most importantly it will result in a
product of a deﬁned size, no matter where the precise integration
junction. Upon sequencing of the product, a deﬁning character-
istic is a junction between AAVS1 sequences and vector sequences
at the chosen restriction site. Fig. 9(B) shows such a PCR using
primers from the left end of the rAAV genome, for the two clones
for which Nla/Inv PCR showed junctions at the left end. Sequen-
cing of the PCR product gave the expected result.Discussion
A long accepted view is that AAV preferentially integrates into the
AAVS1 region of chromosome 19. However, two recent investigations
that for the ﬁrst time employed LM-PCR, an unbiased and more
precise method for determining integration locations than had been
used previously, have concluded that the preference for AAV integra-
tion into AAVS1 was minimal. We employed two modiﬁed LM-PCR
procedures to avoid problems that we think were present in those
two studies. With these methods we determined the genomic
location of integrated rAAV vectors in 14 randomly chosen clones
in which integration had occurred in the presence of a wt AAV
coinfection; in 9 of these clones the vector was inserted within the
AAVS1 region. Therefore this study supports the original observationthat Rep mediated integration is preferentially directed towards
AAVS1 (Kotin et al., 1990).
It has also been thought that site-speciﬁc integration of rAAV,
with Rep supplied in trans, would be too inefﬁcient to be useful.
Since we employed no selection procedure that would lead to
elimination of or selection against non-transduced cells we can
derive an estimate for overall efﬁciency. In our assay 1.3% of cells
were stably transduced, and of these, approximately 2/3 demon-
strated site-speciﬁc integration. This is a frequency sufﬁciently
high to make Rep-supported integration into AAVS1 a candidate
methodology for ex vivo targeted gene transfer in which a
correctly targeted cell is identiﬁed for subsequent expansion
and implantation. We described a simple method to identify such
integrants.
The determination of whether an integrated wt AAV genome
or rAAV transgene is located in the AAVS1 region has traditionally
been by Southern hybridizations. A clone is considered positive if
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a rearranged band from AAVS1. Typically there are numerous
supernumerary AAVS1 bands on the gel (in part because rep
induces rearrangements at AAVS1 even without integration)
leading to coincidental cohybridizations. In addition Southern
hybridization with an AAVS1 probe gives no information about
integrations elsewhere in the genome. FISH analysis has also been
employed but provides a very imprecise location for integrated
vectors.
To circumvent these problems, the location of wt AAV2
genomic junctions has more recently been determined by LM-
PCR (Drew et al., 2007; Huser et al., 2010). However PCR of AAV
integrants presents an AAV-speciﬁc challenge, namely the difﬁ-
culty for the PCR polymerase to successfully negotiate the ITR.
Using an exogenously added substrate with an almost complete
ITR, it required the equivalent of 100 genome copies per cell for a
minimally detectable LM-PCR product (data not shown). More-
over, upon sequencing, the resultant product was deleted for
most of the ITR. Consequently junctions with progressively more
complete ITRs can be expected to be less likely to give a PCR
product. Among our 26 clones, there was evidence of substantial
PCR bias, with some clones giving strong bands, some much
weaker bands, and many no bands at all. In addition in almost all
our PCRs there were varying amounts of short products which
sequencing indicated were artifacts due to polymerases dissociat-
ing from the template ITR and rebinding at random locations.
Pooled cloning of PCR products into sequencing vectors followed
by bacterial transformation would produce numbers of clones
proportional to the amount of PCR product and in many cases give
products for junctions that do not exist in the cell. In addition
plasmids containing AAV ITRs transform bacteria less well and
amplify to lower titers (10-fold in our hands) than do plasmids
without an ITR suggesting that bacterial cloning would also select
for junctions with greater ITR deletions. By randomly picking
single cells then amplifying, extracting DNA, and performing PCR
directly with the extracted DNA on each clone individually we
ensure that we start with a representative sample of integrants
and that each is given equal weight in the ﬁnal counting.
In each assay (Table 1) cells coinfected with wt AAV showed a
greater proportion of transformed cells than those infected with
the recombinant virus alone suggesting that wt AAV was support-
ing increased integration of the TRUF11 genome. For further
investigation we chose an assay with a low level of integration
to lessen the probability that cells with an integrated recombi-
nant virus genome would also have an integrated wild type
genome.
Of the 26 randomly picked GFP expressing clones, we were
able to determine chromosomal locations for only 14 (an addi-
tional 5 clones had junctions to AAV or TRUF sequences). Nine of
these fourteen had integration into AAVS1. Most clones that gave
a junction only by Nla/Inv PCR were from the population that had
given no band in regular PCR. Of the 5 new junctions from that
population of 8 clones, 4 were in AAVS1 and 1 was into an AAV
genome. This result is in agreement with our original conjecture
that Rep supported integrants into AAVS1 are more difﬁcult than
other integrants to locate by PCR through the junction.
We were unable to determine a junction for 7 clones. In the
regular LM-PCR, clones for which we could derive no junction
sequence either failed to give a PCR product or gave a PCR product
with more than one sequence. There are several possible causes
for a double sequence, 1. Some putative clonal populations may
have contained more than one clone (cloning was done manu-
ally). 2. A cloned cell might have contained more than one AAV-
TRUF11 integrant. 3. The integrant may have been a tandem
repeat. 4. The polymerase dissociates in the ITR and rebinds at
another locus. The clones in which we failed with Nla/Inv LM-PCReither again gave more than one sequence or failed to accomplish
circular ligation.
Our observation of recombinant viral genome integration into
apparently already integrated viral genomes was unanticipated.
As shown in Table 3, three clones showed a junction with wt AAV
and two with AAV–TRUF11 sequences. A question that arises is
whether these junctions represent an actual virus to virus junc-
tion found in the cellular DNA or a PCR artifact. A possible
scenario for the latter possibility is that the PCR polymerase
while proceeding through the ITR region might dissociate from its
template due to ITR secondary structure then rebind to either the
same DNA fragment at a different point or to a random DNA
fragment in the PCR mix. In the case of the junction with AAV this
seems very unlikely. After 4 post infection passages at a 20:1
dilution followed by expansion from one cell to approximately
200,000 cells the number of non integrated wt AAV genomes
remaining in each cell would make it unlikely that the polymer-
ase would by chance have rebound to an AAV fragment.
A second question that arises is whether these junctions with
viral genomes were formed in the cell before integration into the
cellular genome or did one virus integrate into the genome
followed by a second virus integrating into the ﬁrst virus. We
favor the latter explanation because while joining of free viral
genomes in the cell has been described in many reports it seems
to have been by joining at the ITRs or by homologous recombina-
tion, neither of which would explain these cases.
These integrations resembles the Rep-dependent integration
event of a viral genome into AAVS1; i.e. in both cases integration
into the neighborhood of a Rep binding site (RBS) and associated
Terminal Resolution Site (TRS) except in these events the RBS and
TRS were those of the wt AAV genome rather than the similar RBS
and TRS found in AAVS1. However in AAVS1 integration the
integration junctions are found almost exclusively in the 3’
direction from the putative Rep-dependent nicking site at the
AAVS1 TRS. In the case of the AAV2–TRUF11 junction with AAV2
sequences described in this report, the junction is presumably 5’
to the nicking sites at either end of the wt AAV genome. A
possibility is that the wt AAV genome into which the AAV2–
TRUF11 genome is integrating is present as a tandem repeat.
However, the explanation we favor is based on the observation of
Fig. 8. It suggests that most recombinant virus are integrating into
a very circumscribed region within AAVS1, as previously
described for wt AAV (Henckaerts et al., 2009). We think that in
each of our 5 cases we are seeing the results of two independent
integration events, both likely mediated by the TRS in AAVS1,
both delivering a viral genome to this same locus. If correct this
would imply that these 5 additional clones harbored 10 AAVS1
integrants and that a subset of infected cells was particularly
prone to support site-speciﬁc integration.
The pattern of integrants revealed by Nla/Inv PCR, (Fig. 8 A)
suggests that the mechanism of integration for rAAV vectors,
despite having no p5 promoter region, is the same as for wt AAV.
AAVS1/Inv PCR as described above should identify most clones
with correctly targeted integrants after ex vivo infection. In
practice it would be useful to perform this PCR with primers
from both ends of an rAAV vector since with recombinant vectors
there will be no preference for which end will be closest to
the TRS.
We elected to supply both the transgene and the required Rep
gene by infection, with rAAV and wt AAV respectively, rather than
by transfection. Transfection can lead to integration of the whole
plasmid rather than only the transgene (Surosky et al., 1997) and
is also more damaging to the cell than AAV infection.
(Mitsui et al., 2009) Moreover since AAV can infect a wide range
of cell types, infection is likely to be more versatile in future
applications.
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is integration of the wild type virus. Direct transfection of protein
has also been successfully employed (Lamartina et al., 1998) but
is not feasible in all cell types. A pseudo wt AAV has been used to
deliver Rep, in which the p5 promoter has been replaced by a
promoter such as the SV40 early promoter (Zhang et al., 2007).
This eliminates a sequence within the p5 promoter (designated as
an integration enhancer element) that plays a role in Rep directed
integration (Philpott et al., 2002a; 2002b). Other workers; how-
ever, have reported that this element plays a more important role
in integration of plasmid constructs than it does with integration
of viral genomes (Guilbaud et al., 2008). Hybrid vectors in which
the transgene inserted between AAV ITRs and the AAV Rep
sequence are placed within an adenovirus or herpes virus back-
bone have also been employed (Fraefel et al., 1997; Recchia et al.,
1999; 2004). In addition to reducing the chance of Rep gene
integration hybrid vectors allow for delivery of a larger transgene.
However chimeric viral vectors are difﬁcult to construct and
propagate and also introduce additional problems particular to
the carrier virus. e.g. herpes or adenovirus. Co-infection with a
Rep-containing RNA virus has also been proposed as a way to
minimize genomic insertion of a Rep gene. (McCarty et al., 2004).
It might be noted that while the Rep gene can be toxic due to
down regulation of cellular promoters, integrated copies of wild
type AAV do not seem harmful, presumably because Rep expres-
sion is strongly down regulated in the wild type AAV context.
(Blacklow et al., 1971). Most importantly wt AAV and indeed all
parvoviruses, whether integrated or not integrated, have never
been observed to be tumorigenic. We therefore elected to supply
the AAV Rep protein by a co-infection with a wt AAV (Henckaerts
et al., 2009; Zhang et al., 2007) since this is the form of Rep
delivery which would seem safe if an undetectably low level of
the Rep gene remained in the selected cells. (Of course the clone
chosen for ampliﬁcation and subsequent implantation will be one
in which the wild type AAV genome was not detected.) Of our
original 4 AAVS1 integrants one clearly had co-integration of a
wild type genome. A second has integration at less than one copy
per cell, suggesting an integration of the wt genome that occurred
after sorting. It is possible that other clones may have undetected
integrated Rep genes in a smaller fraction of their cells due to
even later integration events. Nevertheless this data shows that it
is possible for rAAV integration to occur without a dependence
upon cointegration of the accompanying wt virus. By performing
co-infection at MOIs such that only a low percentage of cells have
integration events and by allowing sufﬁcient cell doublings before
single-cell sorting, the problem of co-integrating wt AAV can be
minimized.
Recently two reports have determined hot spots for AAV
integration using an LM-PCR technology with somewhat different
results (Drew et al., 2007; Huser et al., 2010). Our number of
determined integrants is low but for example among the 14
genomic origins none were near the AAVS2 and AAVS3 loci
reported by one of these groups (Huser et al., 2010). It is
important to note that these workers were measuring integration
of wild type virus whereas we were analyzing integration of
recombinant virus with Rep supplied in trans.
The AAVS1 region into which wt AAV can integrate its genome
seems to be a ‘‘safe harbor’’ integration site for gene delivery
(Hockemeyer et al., 2009; Zou et al., 2011). The presumed safety
of an integrated provirus at this locus is based on lack of
association between infection by wt AAV and transformation of
cells in culture. In addition transgenes integrated into this region
demonstrate robust expression that remains stable through
embryonic stem cell (ESC) or induced pluripotent stem cell (iPSC)
differentiation (Henckaerts and Linden, 2010; Ramachandra
et al.,2011; Smith et al., 2008; Zou et al., 2011).The modiﬁed LM-PCR assays described in this report, in
particular the AAVS1/Inv assay, may be useful in developing
methods to increase the efﬁciency of Rep supported ex vivo
integration into AAVS1 in non-transformed cells and in detecting
these integrants for subsequent expansion and implantation.Materials and Methods
Virus production. Recombinant virus, AAV2–TRUF11, was
produced by transfection of equimolar amounts of pTRUF11,
(Zolotukhin et al., 1996) (This contains an enhanced green
ﬂuorescent protein, GFP. It also contains a Neomycin resistance
gene, however, at no time during these assays were cells treated
with G418.), pXX6, and an AAV2 Rep-Cap construct into non-
conﬂuent HEK 293 T cells. Transfection was mediated by CaCl2.
Cells were harvested at 48 h., centrifuged, resuspended in TE,
frozen and thawed 3X, and benzonase digested. Wild-type AAV2
was produced by infection of HEK 293 T cells with virus produced
from pAV2 (Laughlin et al., 1983) and transfection of pXX6. The
viruses were stored at -80 degrees.
Infection. HEK 293 T and Hep G2 cells were grown in DMEM
with 10% fetal bovine serum. Upon infection cells were main-
tained in DMEM with the addition of Penicillin Streptomycin at
50 ug/ml of each.
Cultures of Hep G2, in 6-well plates at 30% conﬂuence were
coinfected with 3.5108 wt virus in each well and AAV2–TRUF11
at 1.25108 in each well (virus measured as encapsidated vector
genomes).
Media was removed and cells were washed with PBS 24 h after
infection. Upon reaching conﬂuence cells were transferred to
100 mm plates. Cells were thereafter split 20:1 upon reaching
conﬂuence. At each passage, discarded cells were processed for
ﬂow cytometry on a Becton Dickinson FACS Canto ﬂow cytometer
using FACS Diva software.
Cell sorting. Cells were sorted in a Becton Dickinson Inﬂux Cell
Sorter after either 4 or 6 passages dependent upon the percentage
of cells positive for ﬂuorescent by FACS analysis having reached a
fairly constant level and the ﬂuorescent cells on the plates being
present almost entirely in clusters as opposed to being found as
single cells. Individual cells were picked randomly from the
sorted population, (i.e. without knowledge of level of FITC stain-
ing). Clones were grown till approximately 2105 cells. At this
point cells were harvested and DNA isolated by DNeasy (Qiagen).
LM-PCR. Junctions of the AAV2-GFP virus with genomic
sequences were determined by LM-PCR (Schroder et al., 2002).
A small fraction of the DNA from individual clones (approxi-
mately 2000 cell-equivalents) was digested with Nla III. Adapters
made by annealing GTAATACGACTCACTATAGGGCTCGAGAATTCG-
GATCCCGGGCATG and CCCGGGATCC/3InvdT were ligated to 15%
of the digestion products. Two rounds of nested PCR were
performed using 6% of the ligation product. The ﬁrst using primer
TAATACGACTCACTATAGGGCTCG from the adapter and primer
CCATTTACCGTAAGTTATGTAACGC from AAV2-TRUF11, the sec-
ond, primers TATCAAGCTT AGGGCTCGAGAATTCGGATCC from
the adapter and - GTACCT AGGGTACCGAATTCAGATCTAGG from
AAV2-TRUF11. PCR was performed in 25 ul volumes. Conditions
for both ﬁrst and second rounds of PCR were: 941 for 4 min; 30
cycles of 941 for 1 min, 581 for 45 s, 721 for 1 min; 721 for 2 min.
After the ﬁrst round the volume was increased by the addition of
75 ul of sd H2O and 1 ul of this was carried over to the second Rx.
For PCR in which there were large amounts of low molecular
weight products conditions for the ﬁrst round PCR were adjusted
to: 941 for 4 min; 30 cycles of 941 for 1 min, 641 for 45 s—lowered
by 0.21 at each cycle, 721 for 1 min; 721 for 2 min. Bands in this
case were gel recovered. PCR products were sequenced from each
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the other end of the AAV2-GFP virus were investigated by
Tai 1 (Fermentas) digestion followed by ligation to adapters
GTAATACGACTCACTATAGGGCTCGAGAATTCGGATCCCGGGACGT
and CCCGGGATCC/3InvdT. PCR was performed using the same
adapter primers as above but replacing the ﬁrst and second round
TRUF11 primers with CTC GCT GAT CAG CCT CG and TGC CAC TCC
CAC TGT CC respectively. Sequences were searched against the
total nucleotide data base using the BLAST program from the
NLM. Clones were scored as having an identiﬁable junction if the
sequenced PCR product contained the primer juxtaposed to the
ITR, juxtaposed to a genomic sequence. A BLAST search could
unambiguously associate all such junction sequences to a speciﬁc
point in the human genome.
Nla/Inv LM-PCR. DNA from individual clones (2000 cell gen-
ome equivalents) was digested with Pst I. Digestion products
were ligated under dilute conditions, to favor circularization, for
10 h at 161 with T4 ligases from New England Biolabs. This
material was then digested with Nla III as above and ligated with
the same adapter as above. PCR was with the same adapter
primers as above and CTA CAG CTC CTG GGC AAC G for the ﬁrst
round vector primer and TGG TTA TTG TGC TGT CTC ATC ATT TTG
G for the second round vector primer. PCR was performed in 25 ul
volumes. Conditions for the ﬁrst rounds of PCR were: 951 for
2 min; 30 cycles of 951 for 1 min, 601 for 45 s, 721 for 1 min; 721
for 5 min. After the ﬁrst round the volume was increased by the
addition of 75 ul of sdH2O and 1 ul of this was carried over to the
second Rx. The second round was the same except annealing was
for 45 s at 551. Nla/Inv LM-PCR to locate AAV2 junctions was the
same except the vector primers were TCTGATTGAGCAGGCACC
for the ﬁrst round and ACCGTGGCCGAGAAGC for the second
round. First round annealing temperature was 541 and second
round was 571.
AAVS1/Inv PCR. Pst I digestion and ligation were as for Nla/Inv
LM-PCR. PCR was with the same vector primers as Nla/Inv LM-
PCR and GGA CCA CTT TGA GCT CTA CTG G for the ﬁrst round
AAVS1 primer and CCT CTG GCC CAC TGT TTC C for the second
round AAVS1 primer. Conditions for both rounds of PCR were: 951
for 2 min; 32 cycles of 951 for 1 min, 551 for 45 s, 721 for 45 s; 721
for 5 min.Acknowledgments
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